AI-Powered Sepsis Test Shows Promise in Large Clinical Study
TriVerity system demonstrated high sensitivity and specificity across more than 1,200 patients in pivotal SEPSIS-SHIELD trial.
TriVerity system demonstrated high sensitivity and specificity across more than 1,200 patients in pivotal SEPSIS-SHIELD trial.
Vail Scientific, in partnership with Minnetronix, has unveiled a newly designed VSNO sepsis screening device that enhances usability.
A genetic signature in newborns can predict neonatal sepsis before symptoms appear, according to a new study by UBC and SFU researchers.
Cytovale’s IntelliSep test helped support the sepsis management program for Our Lady of the Lake Regional Medical Center.
Read MoreAI-based antimicrobial susceptibility test method promises rapid prediction of antimicrobial resistance using blood of sepsis patients.
Read MoreA new study reveals that the nasal microbiota of ICU patients is more effective than gut microbiota in distinguishing sepsis from non-sepsis.
Read MoreBruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Read MoreThe Sepsis ImmunoScore is an AI/machine learning software as a medical device to guide rapid diagnosis and prediction of sepsis.Â
Read MoreFind out how Cytovale’s IntelliSep test reduced cost of care and improved the efficiency of sepsis care for a large U.S. academic center.
Read MoreThis method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
Read MoreDoctors from Norway received test results two days earlier than before when they tested a new way to analyze blood for suspected sepsis.Â
Read MoreA recent review of advances in pediatric sepsis biomarkers provides an overview of research advancements across various omics levels.
Read MoreResearchers harnessed artificial intelligence to analyze data from over 3.5 million children suffering from sepsis.
Read MoreThe Symphony System is designed to address the need for simple, reliable, rapid, near-patient sepsis testing.
Read MoreCytovale detailed the publication of a new peer-reviewed study that highlights the need for rapid sepsis testing.
Read MoreInflammatix says that the U.S. FDA has granted Breakthrough Device Designation for its TriVerity Acute Infection and Sepsis Test System.Â
Read MoreSiemens Healthineers has contracted with the National Institutes of Health (NIH) to improve antibiotic treatment for sepsis patients.
Read MoreThe test system is intended to be used in emergency department settings in patients with suspected acute infection and sepsis.
Read More